23 May 2013
Keywords: cv, ranexa, cleared, uk, germany, drugmaker, therapeutics
Article | 09 March 2009
US drugmaker CV Therapeutics says Ranexa (ranolazine prolonged-release tablets) has been launched in the UK and Germany by its local ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.